To hear about similar clinical trials, please enter your email below

Trial Title: Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms

NCT ID: NCT06078930

Condition: Gastric Cancer
Tongue Images
Diagnosis

Conditions: Official terms:
Stomach Neoplasms
Disease

Study type: Observational [Patient Registry]

Overall status: Recruiting

Study design:

Time perspective: Prospective

Intervention:

Intervention type: Diagnostic Test
Intervention name: Tongue imaging, tougue coating, saliva, and feces
Description: Tongue images, coating, saliva, and feces on the tongue and clinical data of patients with gastric cancer and healthy participants will be collected.
Arm group label: Healthy participants
Arm group label: Patients with gastric cancer

Summary: In this study, the investigators will prospectively recruit 100,000 individuals, including gastric cancer patients who have not undergone any anti-tumor treatment and non-gastric cancer participants. The investigators will construct a diagnostic model for malignant tumors based on the combination of tongue imaging, tongue coating, saliva, and fecal multi-omics data (including metagenomics, proteomics, metabolomics, etc.). Additionally, it will explore the relationship between oral and intestinal microbiota and the development of malignant tumors.

Detailed description: Patients with gastric cancer were recruited through outpatient clinics, endoscopy units, and inpatient departments of various centers, with all patients requiring a histopathological diagnosis. Non-gastric cancer participants were sourced from community health check-ups, outpatient clinics, and endoscopy units affiliated with these centers.

Criteria for eligibility:

Study pop:
Histologically or cytologically confirmed gastric cancer, and no prior chemotherapy, radiotherapy, biotherapy, immunotherapy or other anti-tumor treatment for malignant tumor. Gastric cancer patients and healthy participants should not have the following conditions: the use of glucocorticoids and antibiotics in the past three months, a history of long-term medication, as well as oral diseases such as tooth and gum diseases.

Sampling method: Non-Probability Sample
Criteria:
Inclusion Criteria for Gastric Cancer Patients: - 18≤age≤90 - Histologically or cytologically confirmed gastric cancer - No prior chemotherapy, radiotherapy, biotherapy, immunotherapy or other anti-tumor treatment for gastric cancer - Subject volunteers to join the study, Signs informed consent, has good compliance and can cooperate with follow-up Exclusion Criteria for Gastric Cancer Patients: - Two or more kinds of malignant tumors at the same time - Gastric cancer that has been treated by chemotherapy, radiotherapy, biotherapy, immunotherapy or other anti-tumor therapy - The use of glucocorticoids and antibiotics in the past three months - History of long-term medication - Presence of oral diseases such as tooth and gum diseases - Subjects who had other factors that might force them to terminate the research ahead of time, such as the development of other severe disease (including mental disease) that required combined treatment, seriously abnormal laboratory examination value, and family or social factors that might affect the subject safety or experimental data collection, as judged by the researchers Inclusion Criteria for Healthy Participants: - 18≤age≤90 - Willingness to participate in the study, signing an informed consent form, and demonstrating good compliance Exclusion Criteria for Healthy Participants: - History of malignant tumors - The use of glucocorticoids and antibiotics in the past three months - History of long-term medication - Presence of oral diseases such as tooth and gum diseases - Subjects who had other factors that might force them to terminate the research ahead of time, such as the development of other severe disease (including mental disease) that required combined treatment, seriously abnormal laboratory examination value, and family or social factors that might affect the subject safety or experimental data collection, as judged by the researchers

Gender: All

Minimum age: 18 Years

Maximum age: 90 Years

Healthy volunteers: Accepts Healthy Volunteers

Locations:

Facility:
Name: Zhejiang Cancer Hospital

Address:
City: Hangzhou
Zip: 310022
Country: China

Status: Recruiting

Contact:
Last name: Cheng Xiangdong, MD

Phone: +0086-571-88128041
Email: Chengxd516@126.com

Contact backup:
Last name: Zhiyuan Xu

Phone: 0086-571-88128041
Email: getfar@foxmai.com

Start date: June 1, 2021

Completion date: December 31, 2026

Lead sponsor:
Agency: Zhejiang Cancer Hospital
Agency class: Other

Collaborator:
Agency: Sichuan Cancer Hospital and Research Institute
Agency class: Other

Collaborator:
Agency: The First Affiliated Hospital of Zhejiang Chinese Medical University
Agency class: Other

Collaborator:
Agency: Wenzhou Medical University
Agency class: Other

Collaborator:
Agency: Fujian Cancer Hospital
Agency class: Other

Collaborator:
Agency: RenJi Hospital
Agency class: Other

Collaborator:
Agency: Tongde Hospital of Zhejiang
Agency class: Other

Collaborator:
Agency: Kecheng District People's Hospital
Agency class: Other

Collaborator:
Agency: Yueyang Central Hospital
Agency class: Other

Collaborator:
Agency: Shandong Cancer Hospital and Institute
Agency class: Other

Collaborator:
Agency: Shanxi Province Cancer Hospital
Agency class: Other

Collaborator:
Agency: Liaoning Tumor Hospital & Institute
Agency class: Other

Collaborator:
Agency: Harbin Cancer Hospital
Agency class: Other

Collaborator:
Agency: Yuhang District People's Hospital
Agency class: Other

Collaborator:
Agency: Hainan Cancer Hospital
Agency class: Other

Collaborator:
Agency: Zigong Fourth People's Hospital
Agency class: Other

Collaborator:
Agency: Henan University of Science and Technology
Agency class: Other

Collaborator:
Agency: Shangyu People's Hospital of Shaoxing City
Agency class: Other

Collaborator:
Agency: Red Cross Hospital, Hangzhou, China
Agency class: Other

Collaborator:
Agency: Hangzhou Normal University Affiliated Hospital
Agency class: Other

Collaborator:
Agency: Xiaoshan District First People's Hospital
Agency class: Other

Collaborator:
Agency: Xianju County People's Hospital
Agency class: Other

Collaborator:
Agency: Lin'an District First People's Hospital
Agency class: Other

Collaborator:
Agency: First Affiliated Hospital of Wenzhou Medical University
Agency class: Other

Collaborator:
Agency: Wenzhou Central Hospital
Agency class: Other

Collaborator:
Agency: Ruian City People's Hospital
Agency class: Other

Collaborator:
Agency: Leqing City People's Hospital
Agency class: Other

Collaborator:
Agency: The Affiliated Hospital of Medical School of Ningbo University
Agency class: Other

Collaborator:
Agency: Cixi City People's Hospital
Agency class: Other

Collaborator:
Agency: Mingzhou Hospital, Zhejiang University
Agency class: Other

Collaborator:
Agency: Fourth Hospital of Ningbo City
Agency class: Other

Collaborator:
Agency: Fenghua District People's Hospital
Agency class: Other

Collaborator:
Agency: Fenghua Traditional Chinese Medicine Hospital, Ningbo City
Agency class: Other

Collaborator:
Agency: Xikou Hospital, Fenghua District, Ningbo City
Agency class: Other

Collaborator:
Agency: Chengdu University of Traditional Chinese Medicine
Agency class: Other

Collaborator:
Agency: Guang'an Hospital, Affiliated to Chengdu University of Traditional Chinese Medicine
Agency class: Other

Collaborator:
Agency: Jiangsu Cancer Institute & Hospital
Agency class: Other

Collaborator:
Agency: Jiangsu Provincial People's Hospital
Agency class: Other

Collaborator:
Agency: The First People's Hospital of Changzhou
Agency class: Other

Collaborator:
Agency: The First Affiliated Hospital of Soochow University
Agency class: Other

Collaborator:
Agency: Jiangsu Provincial Hospital of Traditional Chinese Medicine
Agency class: Other

Collaborator:
Agency: Zidong Campus of Jiangsu Provincial Hospital of TCM
Agency class: Other

Collaborator:
Agency: Wuxi Traditional Chinese Medicine Hospital
Agency class: Other

Collaborator:
Agency: First Affiliated Hospital of Harbin Medical University
Agency class: Other

Collaborator:
Agency: The First Affiliated Hospital of Anhui Medical University
Agency class: Other

Collaborator:
Agency: Peking University Cancer Hospital & Institute
Agency class: Other

Collaborator:
Agency: Xijing Hospital
Agency class: Other

Collaborator:
Agency: Guangdong Provincial Hospital of Traditional Chinese Medicine
Agency class: Other

Collaborator:
Agency: Xiangya Hospital of Central South University
Agency class: Other

Collaborator:
Agency: Yunnan Cancer Hospital
Agency class: Other

Collaborator:
Agency: Chongqing University Cancer Hospital
Agency class: Other

Collaborator:
Agency: Gansu Cancer Hospital
Agency class: Other

Collaborator:
Agency: Fudan University
Agency class: Other

Collaborator:
Agency: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Agency class: Other

Collaborator:
Agency: First Affiliated Hospital of Guangxi Medical University
Agency class: Other

Collaborator:
Agency: Tianjin Medical University Cancer Institute and Hospital
Agency class: Other

Collaborator:
Agency: Huzhou Central Hospital, Zhejiang
Agency class: Other

Collaborator:
Agency: Zhoushan Hospital, Zhejiang
Agency class: Other

Source: Zhejiang Cancer Hospital

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06078930

Login to your account

Did you forget your password?